Creatine for treating muscle disorders.
暂无分享,去创建一个
[1] U. Sharma,et al. Effect of creatine monohydrate in improving cellular energetics and muscle strength in ambulatory Duchenne muscular dystrophy patients: a randomized, placebo-controlled 31P MRS study. , 2010, Magnetic resonance imaging.
[2] D. Altman,et al. Chapter 8: Assessing risk of bias in included studies , 2008 .
[3] D. Theisen,et al. Effects of resistance exercise with and without creatine supplementation on gene expression and cell signaling in human skeletal muscle. , 2008, Journal of applied physiology.
[4] A. Manzur,et al. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. , 2008, The Cochrane database of systematic reviews.
[5] Jimmy D Bell,et al. Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial. , 2007, Arthritis and rheumatism.
[6] M. Beal,et al. Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders , 2007, Muscle & nerve.
[7] A. Shao,et al. Risk assessment for creatine monohydrate. , 2006, Regulatory toxicology and pharmacology : RTP.
[8] M. F. Beal,et al. Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′dG , 2006, Neurology.
[9] M. Francaux,et al. Effect of oral creatine supplementation on urinary methylamine, formaldehyde, and formate. , 2005, Medicine and science in sports and exercise.
[10] K. Chad,et al. Creatine monohydrate and resistance training increase bone mineral content and density in older men. , 2005, The journal of nutrition, health & aging.
[11] A. Pestronk,et al. CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy , 2005, Annals of neurology.
[12] L. H. van den Berg,et al. Few adverse effects of long-term creatine supplementation in a placebo-controlled trial. , 2005, International journal of sports medicine.
[13] T. Klockgether,et al. Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo‐controlled, double‐blind 31P‐MRS crossover study , 2005, European journal of neurology.
[14] T. Conrad,et al. A clinical trial of creatine in ALS , 2004, Neurology.
[15] J. Farthing,et al. Effect of creatine ingestion after exercise on muscle thickness in males and females. , 2004, Medicine and science in sports and exercise.
[16] N. Hattori,et al. [A clinical trial of creatine monohydrate in muscular dystrophy patients]. , 2004, Rinsho shinkeigaku = Clinical neurology.
[17] M. Tarnopolsky,et al. Resistance training exercise and creatine in patients with Charcot–Marie–Tooth disease , 2004, Muscle & nerve.
[18] Robert H. Brown,et al. Prophylactic Creatine Administration Mediates Neuroprotection in Cerebral Ischemia in Mice , 2004, The Journal of Neuroscience.
[19] M. Tarnopolsky,et al. Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy , 2004, Neurology.
[20] M. Rose,et al. Drug treatment for facioscapulohumeral muscular dystrophy. , 2004, The Cochrane database of systematic reviews.
[21] M. Beal,et al. Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase , 2004, Neurobiology of Disease.
[22] M. Tarnopolsky,et al. Attenuation of free radical production and paracrystalline inclusions by creatine supplementation in a patient with a novel cytochrome b mutation , 2004, Muscle & nerve.
[23] P. Clarkson,et al. Effects of repeated creatine supplementation on muscle, plasma, and urine creatine levels. , 2004 .
[24] M. Tarnopolsky,et al. Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1 , 2004, Muscle & nerve.
[25] M. Tarnopolsky,et al. Effect of creatine and weight training on muscle creatine and performance in vegetarians. , 2003, Medicine and science in sports and exercise.
[26] S. Swinnen,et al. Creatine supplementation in Huntington’s disease , 2003, Neurology.
[27] S. Hersch,et al. Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice , 2003, Journal of neurochemistry.
[28] F. Goubel,et al. Beneficial effects of creatine supplementation in dystrophic patients , 2003, Muscle & nerve.
[29] J. Veldink,et al. A randomized sequential trial of creatine in amyotrophic lateral sclerosis , 2003, Annals of neurology.
[30] C. Wessig,et al. Creatine monohydrate in DM2/PROMM , 2003, Neurology.
[31] C. Rasmussen,et al. Long-term creatine supplementation does not significantly affect clinical markers of health in athletes , 2003, Molecular and Cellular Biochemistry.
[32] C. Rasmussen,et al. Creatine supplementation during college football training does not increase the incidence of cramping or injury , 2003, Molecular and Cellular Biochemistry.
[33] A. Persky,et al. Single‐ and Multiple‐Dose Pharmacokinetics of Oral Creatine , 2003, Journal of clinical pharmacology.
[34] H. Hautmann,et al. Creatine monohydrate in myotonic dystrophy , 2002, Journal of Neurology.
[35] M. Tarnopolsky,et al. Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats. , 2002, Canadian journal of physiology and pharmacology.
[36] E. Moser,et al. Effects of Oral Creatine Supplementation in a Patient with MELAS Phenotype and Associated Nephropathy , 2002, Neuropediatrics.
[37] U. Ruegg,et al. Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice , 2002, Neuromuscular Disorders.
[38] K. Chad,et al. Creatine supplementation combined with resistance training in older men. , 2001, Medicine and science in sports and exercise.
[39] G. Mora,et al. Effects of creatine supplementation on exercise performance and muscular strength in amyotrophic lateral sclerosis: preliminary results , 2001, Journal of the Neurological Sciences.
[40] K. Yarasheski,et al. Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed-muscle protein synthesis. , 2001, Journal of applied physiology.
[41] O. Andreassen,et al. Creatine Increases Survival and Delays Motor Symptoms in a Transgenic Animal Model of Huntington's Disease , 2001, Neurobiology of Disease.
[42] M. Tarnopolsky,et al. Creatine transporter and mitochondrial creatine kinase protein content in myopathies , 2001, Muscle & nerve.
[43] L. Wilkins,et al. Activate your online subscription , 2001, Neurology.
[44] A. Straube,et al. A placebo-controlled crossover trial of creatine in mitochondrial diseases , 2000, Neurology.
[45] M. Tarnopolsky,et al. Creatine monohydrate supplementation enhances high-intensity exercise performance in males and females. , 2000, International journal of sport nutrition and exercise metabolism.
[46] M. Mattson,et al. Dietary supplement creatine protects against traumatic brain injury , 2000, Annals of neurology.
[47] N. Olsen,et al. Muscle abnormalities in juvenile dermatomyositis patients: P-31 magnetic resonance spectroscopy studies. , 2000, Arthritis and rheumatism.
[48] M. Francaux,et al. Adverse Effects of Creatine Supplementation , 2000, Sports medicine.
[49] M. Wyss,et al. Creatine and creatinine metabolism. , 2000, Physiological reviews.
[50] M. Tegenthoff,et al. Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial. , 2000, Archives of neurology.
[51] Ole A. Andreassen,et al. Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease , 2000, The Journal of Neuroscience.
[52] Hanns Lochmüller,et al. Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study , 2000, Neurology.
[53] G J Brewer,et al. Protective Effect of the Energy Precursor Creatine Against Toxicity of Glutamate and β‐Amyloid in Rat Hippocampal Neurons , 2000, Journal of neurochemistry.
[54] M. Beal,et al. Neuroprotective effects of creatine administration against NMDA and malonate toxicity , 2000, Brain Research.
[55] S. Felber,et al. Oral creatine supplementation in Duchenne muscular dystrophy: A clinical and 31 P magnetic resonance spectroscopy study , 2000, Neurological research.
[56] M. Tarnopolsky,et al. Acute creatine loading increases fat-free mass, but does not affect blood pressure, plasma creatinine, or CK activity in men and women. , 2000, Medicine and science in sports and exercise.
[57] R. Kreis,et al. Creatine supplementation--part I: performance, clinical chemistry, and muscle volume. , 1999, Medicine and science in sports and exercise.
[58] F. Hanefeld,et al. Supplementation with creatine monohydrate in children with mitochondrial encephalomyopathies , 1999, Muscle & nerve.
[59] M. Tarnopolsky,et al. Direct measurement of high‐energy phosphate compounds in patients with neuromuscular disease , 1999, Muscle & nerve.
[60] P. Dechent,et al. Increase of total creatine in human brain after oral supplementation of creatine-monohydrate. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.
[61] M. Francaux,et al. Long-term oral creatine supplementation does not impair renal function in healthy athletes. , 1999, Medicine and science in sports and exercise.
[62] Ole A. Andreassen,et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis , 1999, Nature Medicine.
[63] M. Tarnopolsky,et al. Creatine monohydrate increases strength in patients with neuromuscular disease , 1999, Neurology.
[64] U. Rüegg,et al. Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells , 1998, FEBS letters.
[65] M. Tarnopolsky,et al. Oral Creatine Supplementation and Athletic Performance: A Critical Review , 1998, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.
[66] M. Wyss,et al. The therapeutic potential of oral creatine supplementation in muscle disease. , 1998, Medical hypotheses.
[67] C. Maganaris,et al. Creatine supplementation enhances maximum voluntary isometric force and endurance capacity in resistance trained men. , 1998, Acta physiologica Scandinavica.
[68] M. Beal,et al. Creatine and Cyclocreatine Attenuate MPTP Neurotoxicity , 1998, Experimental Neurology.
[69] Bruce R. Rosen,et al. Neuroprotective Effects of Creatine and Cyclocreatine in Animal Models of Huntington’s Disease , 1998, The Journal of Neuroscience.
[70] M. Tarnopolsky,et al. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies , 1997, Muscle & nerve.
[71] E. Romanus,et al. A functional index in myositis. , 1996, The Journal of rheumatology.
[72] G Cederblad,et al. Muscle creatine loading in men. , 1996, Journal of applied physiology.
[73] D. Constantin-Teodosiu,et al. Creatine ingestion favorably affects performance and muscle metabolism during maximal exercise in humans. , 1996, The American journal of physiology.
[74] L. Hagenfeldt,et al. Creatine treatment in MELAS. , 1994, Muscle & nerve.
[75] J. Boen,et al. Cloning and sequencing of rat kidney L-arginine:glycine amidinotransferase. Studies on the mechanism of regulation by growth hormone and creatine. , 1994, The Journal of biological chemistry.
[76] C. Partain,et al. Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis. , 1994, Arthritis and rheumatism.
[77] E Hultman,et al. Influence of oral creatine supplementation of muscle torque during repeated bouts of maximal voluntary exercise in man. , 1993, Clinical science.
[78] M. Dalakas,et al. Treatment of inclusion‐body myositis with high‐dose intravenous immunoglobulin , 1993, Neurology.
[79] M. Kilimann,et al. A Na(+)-dependent creatine transporter in rabbit brain, muscle, heart, and kidney. cDNA cloning and functional expression. , 1993, The Journal of biological chemistry.
[80] M. Wyss,et al. Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism. , 1992, Biochimica et biophysica acta.
[81] E Hultman,et al. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. , 1992, Clinical science.
[82] P. Matthews,et al. In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondria1 disease , 1991, Neurology.
[83] P. Matthews,et al. Phosphorus magnetic resonance spectroscopy of brain in mitochondrial cytopathies , 1990, Annals of neurology.
[84] V. Dubowitz,et al. Quantitation of muscle function in children: A prospective study in duchenne muscular dystrophy , 1982, Muscle & nerve.
[85] G. Lancia,et al. PHOSPHOCREATININE IN MYOTONIC DYSTROPHY (STEINERT'S DISEASE) , 1979, The Lancet.
[86] B. Gualano,et al. Exploring the therapeutic role of creatine supplementation , 2009, Amino Acids.
[87] M. Tarnopolsky,et al. Global and targeted gene expression and protein content in skeletal muscle of young men following short-term creatine monohydrate supplementation. , 2008, Physiological genomics.
[88] Gianni Parise,et al. Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.
[89] C. Pieper,et al. Competing risk of household expansion or institutionalization in late life. , 2003, The journals of gerontology. Series B, Psychological sciences and social sciences.
[90] F. Hanefeld,et al. Effectiveness of creatine monohydrate in mitochondrial encephalomyopathies. , 2003, Pediatric neurology.
[91] J. Malin,et al. Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study. , 2002, Archives of neurology.
[92] J. Stout,et al. Effects of resistance exercise and creatine supplementation on myasthenia gravis: a case study. , 2001, Medicine and science in sports and exercise.
[93] W. Kraemer,et al. American College of Sports Medicine roundtable. The physiological and health effects of oral creatine supplementation. , 2000, Medicine and science in sports and exercise.
[94] R. Price,et al. Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis. , 1995, Arthritis and rheumatism.
[95] M. Wyss,et al. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. , 1992, The Biochemical journal.
[96] J. Jourdain,et al. [Dermatomyositis with cardiac involvment and trial treatment with phosphocreatine]. , 1972, Bulletin de la Societe francaise de dermatologie et de syphiligraphie.
[97] M. Weber,et al. [Trial therapy of acute polymyositis with phosphocreatine]. , 1967, Bulletin de la Societe francaise de dermatologie et de syphiligraphie.